Publication
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer …
01 Ocak 2024
Makale
Google Scholar
Authors
Atıf kopyala
P. S. YALÇIN (2024). The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer …. *International journal of clinical oncology 29 (3), 258-265, 2024*.
Yayın bilgileri
Dergi
International journal of clinical oncology 29 (3), 258-265, 2024
Veri tabanı
Google Scholar
Kaynak
GoogleScholar
Atıf verisi 16 Kasım 2026 tarihinde güncellendi.
HÇ Yıldırım, Y Kutlu, E Mutlu, MB Aykan, M Korkmaz, S Yalçın, T Şakalar, ... | International journal of clinical oncology 29 (3), 258-265, 2024
Citations by source
| Kaynak | Atıf |
|---|---|
| Google Scholar | 11 |
| Etkin | 0 |
Yayın metrikleri (GS / WoS / Scopus)
GS
11
Google Scholar Atıf
Other publications by authors
Other academic outputs by the same KKU authors — newest first.
İlgili yayınlar yükleniyor…
İlgili yayın bulunamadı.